Schedule 13D ownership disclosure

Supernus Pharmaceuticals Inc

Security class unavailable · CUSIP: 868459108

Event date: 2019-03-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,747,265
Percent of class
5.1300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-19-023500
Form type
SC 13D
Filer
Khattar Jack A.
CIK
CIK 1539937
Filed
Apr 25, 2019
Reporting period
Mar 01, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub